ICD/CRT-D Lead Study
A Survey of Thirty-Nine Electrophysiologists
Deliverable: Survey with key findings.
Study Description:
|
Topic |
Electrophysiologists perceptions and usage of ICD/CRT-D leads. |
|
Respondent Type |
Physicians |
|
Specialties Covered |
Electrophysiologists |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website Duration: 20 minutes Size: 39 respondents Fielding Dates: November 27th to 30th 2007 |
Objectives:
To understand electrophysiologist’s perceptions and usage of ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device & defibrillation) leads.
§ To comprehend the current market and estimate the growth in the number of ICD/CRT-D procedures over the next 3 years
§ To determine the current and future use of ICD/CRT-D leads from various manufacturers
§ To gauge the impact of Medtronic Sprint Fidelis recall
§ To evaluate electrophysiologists perceptions of product differentiation
§ To understand the perceptions and use of ICDs with remote monitoring
§ To gauge the impact of reimbursement on usage of ICDs with remote monitoring
Companies Mentioned In This Report:
|
Medtronic |
MDT |
|
|
BSX |
|
|
STJ |
|
Biotronik |
|
|
Sorin |
RIJ.MU |
Inclusion Criteria and Respondent Demographics
|
Inclusion Criteria
|
§ US-based electrophysiologists § Board-certified/board eligible in specialty § 2 to 30 years of experience post-training § Minimum of 75% professional time spent in clinical practice § Perform at least 10 ICD/CRT-D implants per month |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |